ChristianaCare spins off start-up company using its gene editing technology

AdvertisementChristianaCare has spun out its first commercial biotechnology start-up, CorriXR Therapeutics with $5 million in seed funding CorriXR Therapeutics (pronounced Cor-ix-er; from Galician meaning to correct or edit) will use … Continue reading ChristianaCare spins off start-up company using its gene editing technology